Leadership

Directors

Ronald D. Guttmann, MD, FRCPC. Dr. Guttmann is Emeritus Professor of Medicine and former Director of the McGill University Centre for Clinical Immunobiology and Transplantation. Dr. Guttmann has been active in the biomedical industry and biotechnology investment consulting since 1985.

Mark Allegretta, PhD. Dr. Allegretta has over 30 years of experience in biotechnology and academic research and development. He received his PhD from the University of Vermont in 1990, and was a post-doctoral fellow at Stanford University School of Medicine. Dr. Allegretta is a BioMosaics co-founder and held postions in Connetics Corporation and InterMune Pharmaceuticals. He was most recently Vice President of Research for the National Multiple Sclerosis Society and currently has transitioned to part-time as Senior Director of Research.

Thomas S. Gillespie, B.C.L. Mr. Gillespie is the former President of Tyringham Investments and prior to 2001 he was a Senior Partner of Ogilvy Renault, a major Canadian law firm, where he was a member of the firm’s Executive Committee for ten years. Mr. Gillespie has served as a director or officer of a number of corporations including Volvo Canada, Guerlin Canada, Imperial Tobacco of Canada, and the Daily Mail and General Trust, England.